If the glucose concentration is <60 mg/dL, repeat the test and treat. Reduce the insulin infusion rate by 50% if tube feeding or TPN is stopped abruptly. Revert to hourly capillary blood glucose ...

Additionally, connectivity-enabled central dashboards in infusion therapy, such as OSAA Innovation’s iV-VIEW dashboard, use the data transferred from every connected device and can identify the ...

Tegoprubart and mycophenolate mofetil (MMF) were given as the immunosuppressant therapy in the study, every third week by intravenous infusion, with the first two subjects achieving insulin ...

TEPEZZA, as the first FDA-approved treatment for thyroid eye disease, marks a major breakthrough in managing TED, addressing a critical medical gap for patients who have long had few treatment ...

Rezolute advances therapies for hypoglycemia with RZ358 and RZ402, showing efficacy in trials. Read why RZLT stock is a compelling, albeit cautious, investment.

350 mg/20 mL every four weeks injection for IV infusion), Eli Lilly and Company's (NYSE: LLY) Alzheimer's treatment for adults with early symptomatic Alzheimer's disease, which includes people ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

In type 2 diabetes, which is characterized by diminished and delayed endogenous insulin release ... intramuscular; IV, intravenous; SC, subcutaneous. Chris Rayner is the Gwendolyn Michell Senior ...